Urinary Dickkopf-3 (DKK3) Is Associated with Greater eGFR Loss in Patients with Resistant Hypertension

Patients with resistant hypertension (HTN) demonstrate an increased risk of chronic kidney disease and progression to end-stage renal disease; however, the individual course of progression is hard to predict. Assessing the stress-induced, urinary glycoprotein Dickkopf-3 (uDKK3) may indicate ongoing renal damage and consecutive estimated glomerular filtration rate (eGFR) decline. The present study aimed to determine the association between uDKK3 levels and further eGFR changes in patients with resistant HTN. In total, 31 patients with resistant HTN were included. Blood pressure and renal function were measured at baseline and up to 24 months after (at months 12 and 24). uDKK3 levels were determined exclusively from the first available spot urine sample at baseline or up to a period of 6 months after, using a commercial ELISA kit. Distinctions between different patient groups were analyzed using the unpaired t-test or Mann–Whitney test. Correlation analysis was performed using Spearman’s correlation. The median uDKK3 level was 303 (interquartile range (IQR) 150–865) pg/mg creatinine. Patients were divided into those with high and low eGFR loss (≥3 vs. <3 mL/min/1.73 m²/year). Patients with high eGFR loss showed a significantly higher median baseline uDKK3 level (646 (IQR 249–2555) (n = 13) vs. 180 (IQR 123–365) pg/mg creatinine (n = 18), p = 0.0412 (Mann–Whitney U)). Alternatively, patients could be classified into those with high and low uDKK3 levels (≥400 vs. <400 pg/mg creatinine). Patients with high uDKK3 levels showed significantly higher eGFR loss (−6.4 ± 4.7 (n = 11) vs. 0.0 ± 7.6 mL/min/1.73 m2/year (n = 20), p = 0.0172 (2-sided, independent t-test)). Within the entire cohort, there was a significant correlation between the uDKK3 levels and change in eGFR at the latest follow-up (Spearman’s r = −0.3714, p = 0.0397). In patients with resistant HTN, high levels of uDKK3 are associated with higher eGFR loss up to 24 months later.

[1]  P. Boor,et al.  Measurement of urinary Dickkopf-3 uncovered silent progressive kidney injury in patients with chronic obstructive pulmonary disease. , 2021, Kidney international.

[2]  C. Quintavalle,et al.  Urinary Dickkopf-3 and Contrast-Associated Kidney Damage. , 2021, Journal of the American College of Cardiology.

[3]  J. Staessen,et al.  Proteomic Biomarkers in the Cardiorenal Syndrome: Toward Deciphering Molecular Pathophysiology. , 2021, American journal of hypertension.

[4]  Jing Hu,et al.  Dickkopf-3: Current Knowledge in Kidney Diseases , 2020, Frontiers in Physiology.

[5]  N. Babel,et al.  Dickkopf-3 in the prediction of contrast media induced acute kidney injury , 2020, Journal of Nephrology.

[6]  J. Kellum,et al.  Association between urinary dickkopf-3, acute kidney injury, and subsequent loss of kidney function in patients undergoing cardiac surgery: an observational cohort study , 2019, The Lancet.

[7]  H. Dihazi,et al.  Dickkopf-3 in aberrant endothelial secretome triggers renal fibroblast activation and endothelial–mesenchymal transition , 2019, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[8]  C. Fitzner,et al.  Urinary Biomarkers in the Prediction of Prognosis and Treatment Response in IgA Nephropathy , 2018, Kidney and Blood Pressure Research.

[9]  M. Rudnicki,et al.  Dickkopf-3 (DKK3) in Urine Identifies Patients with Short-Term Risk of eGFR Loss. , 2018, Journal of the American Society of Nephrology : JASN.

[10]  F. Zannad,et al.  Cardiorenal Syndrome Revisited , 2018, Circulation.

[11]  L. Lv,et al.  Renal tubule injury: a driving force toward chronic kidney disease. , 2018, Kidney international.

[12]  Qingbo Xu,et al.  DKK3 (Dickkopf 3) Alters Atherosclerotic Plaque Phenotype Involving Vascular Progenitor and Fibroblast Differentiation Into Smooth Muscle Cells , 2018, Arteriosclerosis, thrombosis, and vascular biology.

[13]  Qingbo Xu,et al.  Dickkopf 3 ) Alters Atherosclerotic Plaque Phenotype Involving Vascular Progenitor and Fibroblast Differentiation Into Smooth Muscle Cells , 2018 .

[14]  D. Bolignano,et al.  Non‐proteinuric rather than proteinuric renal diseases are the leading cause of end‐stage kidney disease: Clinical Epidemiology in Nephrology , 2017, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[15]  R. Wachter,et al.  Effects of Baroreflex Activation Therapy on Ambulatory Blood Pressure in Patients With Resistant Hypertension , 2016, Hypertension.

[16]  Y. Liu,et al.  Downregulation of renal tubular Wnt/β-catenin signaling by Dickkopf-3 induces tubular cell death in proteinuric nephropathy , 2016, Cell Death and Disease.

[17]  T. Hielscher,et al.  Tubular Dickkopf-3 promotes the development of renal atrophy and fibrosis. , 2016, JCI insight.

[18]  F. Kronenberg,et al.  Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis. , 2016, JAMA.

[19]  R. Wachter,et al.  Impact of Baroreflex Activation Therapy on Renal Function - A Pilot Study , 2014, American Journal of Nephrology.

[20]  J. Coresh,et al.  Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. , 2014, JAMA.

[21]  R. Minutolo,et al.  Prevalence and prognostic role of resistant hypertension in chronic kidney disease patients. , 2013, Journal of the American College of Cardiology.

[22]  R. Colvin,et al.  Renal interstitial fibrosis: mechanisms and evaluation , 2012, Current opinion in nephrology and hypertension.

[23]  Heather M. Tavel,et al.  Incidence and Prognosis of Resistant Hypertension in Hypertensive Patients , 2012, Circulation.

[24]  H. Yamada,et al.  Expression pattern of REIC/Dkk-3 in various cell types and the implications of the soluble form in prostatic acinar development. , 2010, International journal of oncology.

[25]  B. Kestenbaum,et al.  Rapid decline of kidney function increases cardiovascular risk in the elderly. , 2009, Journal of the American Society of Nephrology : JASN.

[26]  E. Neilson,et al.  Toward a unified theory of renal progression. , 2006, Annual review of medicine.

[27]  E. Muxfeldt,et al.  Twenty-four hour ambulatory blood pressure monitoring pattern of resistant hypertension , 2003, Blood pressure monitoring.